| Bioactivity | Mirogabalin-13C2,d1 (Mixture of Diastereomers) is a C13 and deuterium labeled Mirogabalin. Mirogabalin (DS-5565) is a novel, preferentially selective α2δ-1 ligand characterized by high potency and selectivity to the α2δ-1 subunit of voltage-sensitive calcium channel complexes in the CNS[1]. |
| Name | Mirogabalin-13C2,d1 (Mixture of Diastereomers) |
| Formula | C1013C2H18DNO2 |
| Molar Mass | 212.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Vinik A, et al. Efficacy and safety of Mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. Diabetes Care. 2014 Dec[1]. |
Mirogabalin-13C2,d1 (Mixture of Diastereomers)
CAS: F: C1013C2H18DNO2 W: 212.28
Mirogabalin-13C2,d1 (Mixture of Diastereomers) is a C13 and deuterium labeled Mirogabalin. Mirogabalin (DS-5565) is a no
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.